Norihiro Suzuki

7PUBLICATIONS
33CO-AUTHORS
Traditional Chinese medicine and treatmentsEpidemiological methodsMolecular medicineNeurology and neuromuscular diseasesImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 23, 2021
Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study.

Fumihiko Sakai, Norihiro Suzuki, Xiaoping Ning

|Jul 29, 2021
Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Fumihiko Sakai, Norihiro Suzuki, Byung-Kun Kim

|Jul 29, 2021
Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Fumihiko Sakai, Norihiro Suzuki, Byung-Kun Kim

|Jul 17, 2019
Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis.

Y Nishida, Y K Takahashi, T Kanai

|Nov 10, 2017
RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration.

Daisuke Ito, Mami Hatano, Norihiro Suzuki

|Nov 09, 2016
A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS).

Nobuko Yamaguchi, Sonoko Misawa, Yasunori Sato

Pageof 2

Frequent Collaborators

3 joint publications

Nobuyuki Koga

3 joint publications

Fumihiko Sakai

2 joint publications

Yoichiro Nishida

2 joint publications

Satoshi Kuwabara